PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Sciformix Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Sciformix Furthers Global Expansion with Newly Strengthened Management Team - Company recognizes crucial roles that operations play as part of overall business strategy to ensure sustained success - Sciformix.com
Sciformix Furthers Global Expansion with Newly Strengthened Management Team

 

NewswireToday - /newswire/ - Boston, MA, United States, 2015/04/28 - Company recognizes crucial roles that operations play as part of overall business strategy to ensure sustained success - Sciformix.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Sciformix Corporation, a leading Scientific Process Organization (SPO), is pleased to announce the appointments of Warun Nayar as Chief Operations Officer (COO) and Abhay Joshi as Chief Finance Officer (CFO). These two new appointments, along with the announcement of David Balderson as Vice President Global Safety Operations in January reinforce Sciformix’s global business expansion and how they continue to invest to support their client’s needs and future growth.

As COO Warun Nayar will spearhead Sciformix’s delivery, practice management, HR, IT and administration functions. Warun brings a formidable body of experience and a proven ability to incentivize, synchronize and stabilize business operations. After a long tenure in the Army, his first corporate job was with Cambridge Technology Partners, where he went on to head the European operations. He spent 14 years at GE Capital International Services (GECIS) which was later rebranded as Genpact and held leadership positions vital in augmenting the growth story of the company. These included CIO for Genpact Europe, Operations Leader for Hungary and Kolkata sites, and then Business Leader for the Manufacturing, Telecom, Chemicals, Logistics, Media and Utilities verticals. His most recent role was Hitachi Operations Lead at Genpact Japan Business Services.

Abhay joins the Sciformix family as the CFO with over 25 years of experience in finance and accounts functions in technology, manufacturing and distribution sector companies worldwide. His areas of expertise include tax and legal compliance, cost management, budgeting and financial planning and MIS. He also has extensive experience in start-ups and managing their growth. Prior to joining Sciformix, Abhay was the finance head of the Enterprise Solutions business group at Tata Consultancy Services. During the course of his career he has worked with leading companies like Johnson & Johnson, IBM distributor company, Cummins and Symantec.

David Balderson, as Global VP of Safety Operations, has made great strides to further strengthen Sciformix’s delivery of global safety and pharmacovigilance (PV) solutions. David brings extensive knowledge and experience that will help enhance the company’s operational excellence, and global PV capabilities. Prior to joining Sciformix, David held senior leadership roles at Amgen US, first as Head of Global Safety Operations and then as Head of Global Regulatory Operations, and in Pharmacovigilance at GSK in the UK prior to that.

On the appointment of Warun, Manish Soman, President and CEO at Sciformix, commented,“He believes and lives by his values and attributes his success in setting up, investing and managing operations that build morale, employee empowerment and a positive culture in all his roles. He is recognized by his peers as a people leader and is a much sought after motivational speaker.”

He added of Abhay,“Abhay has consistently demonstrated success in implementing various systems for enhancing operational efficiency. He brings his proven analytical, negotiation and relationship management skills to Sciformix, which I am sure will prove to be pivotal.”

Sciformix’s long-term strategy focuses on evolving and enhancing our service and technology offerings, broadening our global reach and growing and diversifying the client and revenue base. The appointment of these leaders demonstrates Sciformix’s commitment and investment to support their expanding business.

About Sciformix
Sciformix Corporation (sciformix.com) is a leading Scientific Process Organization (SPO), providing scientific knowledge-based services to pharmaceutical and biopharmaceutical, generics, consumer products, medical devices and other healthcare companies in the areas of Safety and Risk Management, Clinical Research & Post-Approval Support and Regulatory Affairs. Our mission is to partner with global life science companies to provide high quality scientific knowledge-based expertise to deliver better quality outcomes and improved efficiencies across the entire product lifecycle with the ultimate objective of improving quality of healthcare for patients worldwide. Corporate headquarters is located in Westborough, MA with operations in USA, UK, India and the Philippines.

We create value for our clients through our singular focus on the life sciences industry, strong pharmaceutical domain competency, exceptional subject matter expertise, industry reputed advisory board, uncompromising focus on quality, process rigor, predictable results, and ability to scale. Our portfolio of services spans the full spectrum of product lifecycle from pre-clinical and clinical to post marketing activities to help our customers solve complex analytical challenges, improve the quality of patient healthcare and increase client productivity.

Sciformix is dedicated to providing our clients outstanding services and solutions, fuelled by an unrivalled commitment to quality. We share the same level of involvement, dedication and passion as our clients and become an integral part of their team. Our distinct combination of scientific expertise, process rigor and technology innovation delivers consistent, reliable and insightful results. Our ability to scale and grow to meet your evolving needs means we are flexible and dedicated to your success in delivering safe products with more efficiency and greater speed. We help you make the right decisions at the right time by providing Trusted Services Built on Science.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Sciformix Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Sciformix Furthers Global Expansion with Newly Strengthened Management Team

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Sciformix Corporation |
Publisher Contact: Susan Najjar - Sciformix.com 
617-264-0339 susan.najjar[.]sciformix.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Sciformix Corporation securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Sciformix Corporation / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections
Greenphire Receives EU-US Privacy Shield Certification
The 2016 Georges Mathé Prize Recognizes Research on the Immunological Determinants of the Response to Breast Cancer Treatment
MDxHealth Announces Agreement with HIFU CLINIC Prostate Cancer Center for Distribution of SelectMDx in Poland
First Patient in Malaysia Receives TheraSphere™ Radioembolisation Therapy
FDA Approves Genentech’s Lucentis® (Ranibizumab Injection) Prefilled Syringe

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  La Bella Bakery Artisan Bakery Arizona

Visit  Triggr & Bloom





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)